Daniel John Murfin

Title: The Innovations of Daniel John Murfin

Introduction

Daniel John Murfin is an accomplished inventor based in St. Joseph, MO (US). He has made significant contributions to the field of vaccine development, particularly in the quantification of viral proteins. With a total of 2 patents, his work has implications for improving vaccine efficacy and safety.

Latest Patents

Murfin's latest patents focus on the quantification of vaccine compositions. The first patent provides methods and mass-labeled peptides for quantifying the presence of one or more viral proteins in a sample. This is achieved through mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides. Specifically, the viral proteins targeted are antigens in a vaccine for porcine circovirus. The second patent mirrors the first, emphasizing the same innovative methods and applications in vaccine development.

Career Highlights

Throughout his career, Murfin has worked with notable companies in the veterinary health sector. He has been associated with Boehringer Ingelheim Vetmedica GmbH and Boehringer Ingelheim Animal Health USA Inc. His experience in these organizations has allowed him to contribute to advancements in animal health and vaccine technology.

Collaborations

Murfin has collaborated with several professionals in his field, including Marc Allan Eichmeyer and Michael B Roof. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in vaccine quantification.

Conclusion

Daniel John Murfin's contributions to vaccine technology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in veterinary medicine and vaccine efficacy.